Carmona-Pirez J, Salsoso R, Charpentier E, Olmedo C, Medrano F, Roman L
J Fungi (Basel). 2025; 11(2).
PMID: 39997396
PMC: 11857022.
DOI: 10.3390/jof11020102.
Chang C, Tsai C, Tsai F, Chu T, Hsu P, Kuo C
Curr Issues Mol Biol. 2025; 47(2).
PMID: 39996844
PMC: 11854592.
DOI: 10.3390/cimb47020123.
Fujiwara-Tani R, Nakashima C, Ohmori H, Fujii K, Luo Y, Sasaki T
Curr Issues Mol Biol. 2025; 47(2).
PMID: 39996805
PMC: 11854147.
DOI: 10.3390/cimb47020083.
Zhang B, Pang Y
Front Oncol. 2025; 15:1545656.
PMID: 39980566
PMC: 11839597.
DOI: 10.3389/fonc.2025.1545656.
Ahn J, Kim O, Jin S, Ryu J, Lee D, Park W
Ann Surg Treat Res. 2025; 108(2):108-123.
PMID: 39944924
PMC: 11813545.
DOI: 10.4174/astr.2025.108.2.108.
Fructose 1,6-bisphosphatase 1 is a potential biomarker affecting the malignant phenotype and aerobic glycolysis in glioblastoma.
Lu W, Huang G, Yu Y, Zhai X, Zhou X
PeerJ. 2025; 13:e18926.
PMID: 39902328
PMC: 11789649.
DOI: 10.7717/peerj.18926.
Triglyceride-glucose index and triglyceride-glucose-body mass index as prognostic factors for early stage breast cancer patients receiving neoadjuvant chemotherapy.
Li F, Gao T, Li Z, Dou H, Ba Y, Jia S
Transl Oncol. 2025; 53:102292.
PMID: 39884219
PMC: 11814653.
DOI: 10.1016/j.tranon.2025.102292.
Role of Oxidative Stress in the Occurrence, Development, and Treatment of Breast Cancer.
Dong R, Wang J, Guan R, Sun J, Jin P, Shen J
Antioxidants (Basel). 2025; 14(1).
PMID: 39857438
PMC: 11760893.
DOI: 10.3390/antiox14010104.
Transcription factor EB (TFEB) activity increases resistance of TNBC stem cells to metabolic stress.
Soleimani M, Duchow M, Goyal R, Somma A, Kaoud T, Dalby K
Life Sci Alliance. 2025; 8(3).
PMID: 39814550
PMC: 11735543.
DOI: 10.26508/lsa.202302259.
The multifaceted roles of aldolase A in cancer: glycolysis, cytoskeleton, translation and beyond.
Yu S, Xue Y, Chen Y, Cao Y, Yang Y, Ge X
Hum Cell. 2025; 38(2):45.
PMID: 39808355
DOI: 10.1007/s13577-025-01172-4.
IGF1R Enhances Calcium Oxalate Monohydrate-Induced Epithelial-Mesenchymal Transition by Reprogramming Metabolism via the JAK2/STAT3 Signaling.
Pan J, Zhang Y, Yao R, Yang M, Mao X, Song Z
Int J Biol Sci. 2025; 21(1):415-432.
PMID: 39744436
PMC: 11667822.
DOI: 10.7150/ijbs.104311.
The impact of epithelial-mesenchymal transition (EMT) induced by metabolic processes and intracellular signaling pathways on chemo-resistance, metastasis, and recurrence in solid tumors.
Liaghat M, Ferdousmakan S, Mortazavi S, Yahyazadeh S, Irani A, Banihashemi S
Cell Commun Signal. 2024; 22(1):575.
PMID: 39623377
PMC: 11610171.
DOI: 10.1186/s12964-024-01957-4.
Tumor energy metabolism: implications for therapeutic targets.
Hu Y, Liu W, Fang W, Dong Y, Zhang H, Luo Q
Mol Biomed. 2024; 5(1):63.
PMID: 39609317
PMC: 11604893.
DOI: 10.1186/s43556-024-00229-4.
Current hotspots and trends in cancer metabolic reprogramming: a scientometric analysis.
Yang S, Lin M, Hao S, Ye H, Zhang X
Front Immunol. 2024; 15:1497461.
PMID: 39588377
PMC: 11586341.
DOI: 10.3389/fimmu.2024.1497461.
FBP1 over-expression suppresses HIF-1α in papillary thyroid cancer.
Li H, Xie W, Huang X, Chen Y
Sci Rep. 2024; 14(1):29167.
PMID: 39587225
PMC: 11589751.
DOI: 10.1038/s41598-024-81017-6.
Reactive oxygen species from non-thermal gas plasma (CAP): implication for targeting cancer stem cells.
Babajani A, Eftekharinasab A, Bekeschus S, Mehdian H, Vakhshiteh F, Madjd Z
Cancer Cell Int. 2024; 24(1):344.
PMID: 39438918
PMC: 11515683.
DOI: 10.1186/s12935-024-03523-x.
Intracellular checkpoints for NK cell cancer immunotherapy.
Huang Y, Tian Z, Bi J
Front Med. 2024; 18(5):763-777.
PMID: 39340588
DOI: 10.1007/s11684-024-1090-6.
Altered metabolism in cancer: insights into energy pathways and therapeutic targets.
Tufail M, Jiang C, Li N
Mol Cancer. 2024; 23(1):203.
PMID: 39294640
PMC: 11409553.
DOI: 10.1186/s12943-024-02119-3.
Blocking tumor-intrinsic MNK1 kinase restricts metabolic adaptation and diminishes liver metastasis.
Preston S, Dahabieh M, Flores Gonzalez R, Goncalves C, Richard V, Leibovitch M
Sci Adv. 2024; 10(37):eadi7673.
PMID: 39270021
PMC: 11397505.
DOI: 10.1126/sciadv.adi7673.
Novel Anti-Cancer Stem Cell Compounds: A Comprehensive Review.
Guo S, Zheng S, Liu M, Wang G
Pharmaceutics. 2024; 16(8.
PMID: 39204369
PMC: 11360402.
DOI: 10.3390/pharmaceutics16081024.